(PDF) Isolated Trisomy 13 Defines a Homogeneous AML

Isolated Trisomy 13 Defines a Homogeneous AML Subgroup With High Frequency of Mutations in Spliceosome Genes and Poor Prognosis

Blood - United States

doi 10.1182/blood-2013-12-540716

Related search

Mutations in Rb1 Pathway-Related Genes Are Associated With Poor Prognosis in Anaplastic Astrocytomas

British Journal of Cancer

Cancer Research

English

PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup

Multidisciplinary

English

Better Prognosis in Newborns With Trisomy 13 Who Received Intensive Treatments: A Retrospective Study of 16 Patients

Cell Biochemistry and Biophysics

English

Heterogeneity Within AML With CEBPA Mutations; Only CEBPA Double Mutations, but Not Single CEBPA Mutations Are Associated With Favourable Prognosis

British Journal of Cancer

Cancer Research

English

Transformation of MDS/MPN-RS-T to AML: Trisomy 13, Resistant Thrombocytosis and Transient Disease Control With Oral Busulfan Therapy

American Journal of Hematology

English

MB4-2 Breakpoint in MMSET Combined With Del(17p) Defines a Subset of T(4;14) Multiple Myeloma With Very Poor Prognosis

English

BRCAness Combined With Family History of Cancer Is Associated With Poor Prognosis in Breast Cancer Patients With High Risk of BRCA Mutations

Clinical Breast Cancer

Cancer Research

English

AB245. Down-Regulation of C12orf59 Is Associated With a Poor Prognosis and VHL Mutations in Renal Cell Carcinoma

Translational Andrology and Urology

Reproductive Medicine

English

Loss of Tumor Suppressors KAI1 and P27 Identifies a Unique Subgroup of Primary Melanoma Patients With Poor &Shy;prognosis

English